ALVOTECH SA -27 (ALVOW:NASDAQ)
$0.3799 -0.0201 (-5.025%)
Analysed ALVOTECH SA -27 (ALVOW:NASDAQ) News Sources
Alvotech Q2 Earnings Call Highlights
20-08-2026
marketbeat.com
Alvotech Announces Licensing and Commercialization Agreement with Lotus Pharmaceutical for proposed biosimilars to durvalumab and emicizumab in the U.S. and Selected Asian Markets
21-08-2026
yahoo.com
BofA starts bullish Alvotech coverage on biosimilar launch cycle
24-08-2026
yahoo.com
Alvotech (ALVO) Gets New ‘Buy’ Reco. Should Investors Follow?
24-08-2026
yahoo.com
Alvotech to present at upcoming investor conferences in September
27-08-2026
yahoo.com
Bank of America sees major upside in this biotech stock
28-08-2026
thestreet.com
Why Alvotech (ALVO) Is Up 11.7% After Expanding Biosimilar Deal With Lotus Pharmaceutical
29-08-2026
yahoo.com
Has Alvotech (NasdaqGM:ALVO) Fallen Below Fair Value After Its Deal?
29-08-2026
yahoo.com
Alvotech Announces FDA Acceptance for Review of Biologics License Application for AVT80, Expanding Proposed Biosimilar Program for Entyvio® to Subcutaneous Presentations
31-08-2026
yahoo.com
Alvotech announces FDA acceptance for review of Biologics License Application for AVT80, expanding proposed biosimilar program for Entyvio® to subcutaneous presentations
31-08-2026
yahoo.com
What is the current price of ALVOTECH SA -27 (ALVOW:NASDAQ)?
The current price of ALVOTECH SA -27 (ALVOW:NASDAQ) is $0.3799.
ALVOTECH SA -27 (ALVOW:NASDAQ) absolute price change since previous trading day?
The absolute price change of ALVOTECH SA -27 (ALVOW:NASDAQ) since the previous trading day is $-0.0201.
ALVOTECH SA -27 (ALVOW:NASDAQ) percentage price change since previous trading day?
The percentage price change of ALVOTECH SA -27 (ALVOW:NASDAQ) since the previous trading day is -5.025%.
What is the most recent average sentiment score for ALVOTECH SA -27 (ALVOW:NASDAQ)?
The most recent average sentiment score for ALVOTECH SA -27 (ALVOW:NASDAQ) is 74 out of 100.
What is the most recent average sentiment for ALVOTECH SA -27 (ALVOW:NASDAQ)?
The most recent sentiment for ALVOTECH SA -27 (ALVOW:NASDAQ) is .
SEC-8K** Filing Available For ALVOTECH SA -27 (ALVOW:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.